Gedeon Richter has announced that a filing for its RGB-19 Mochida-partnered biosimilar rival to RoActemra (tocilizumab) has been accepted for review by the European Medicines Agency. “The submission o
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Apollo Licenses Ex-China Rights T
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Shionogi Gets Daridorexant’s Japanese D
An advisory committee to Japan’s Ministry of Health, Labour and Welfare (MHLW) has recommended the approval of eight new drugs, including a global-first indication for Eisai Co., Ltd. ’s ultra-high d